The consequences of genetic and pharmacologic reduction in sphingolipid synthesis.

Schiffmann, Raphael

The consequences of genetic and pharmacologic reduction in sphingolipid synthesis. [electronic resource] - Journal of inherited metabolic disease Jan 2015 - 77-84 p. digital

Publication Type: Journal Article; Review

1573-2665

10.1007/s10545-014-9758-8 doi


Animals
Asthma--genetics
Atherosclerosis--genetics
Diabetes Mellitus--genetics
Disease Models, Animal
Glucose--chemistry
Glucosyltransferases--genetics
Humans
Lipid Metabolism--genetics
Lysosomes--metabolism
Mice
Polycystic Kidney Diseases--genetics
Serine C-Palmitoyltransferase--genetics
Sphingolipidoses--genetics
Sphingolipids--biosynthesis
Uridine Diphosphate--chemistry